Why Canada is your investment location of choice

• Highly skilled workers

To meet industry needs, Canada has established a number of organizations to facilitate the recruitment, development, and retention of highly skilled knowledge workers.


• Lowest business costs in the G7

Canada’s cost advantages are clear. KPMG ranked Canada as overall cost leader for the fifth consecutive time in its 2004 international study Competitive Alternatives: The CEO’s Guide to International Business Costs. The study showed that Canada offers a substantial cost advantage over the U.S. in all industries, especially in health-related operations such as biomedical R&D;, clinical trials, pharmaceuticals, and medical device.


• Vibrant R&D; community




• Leading research infrastructure

Canada boasts one of the most extensive and evolved R&D; infrastructures in the world, which propels Canada’s leadership in biotechnology.The National Research Council Canada acts as the anchor for Canada’s R&D; infrastructure. Eleven national research institutes are located across the country to capitalize on regional capabilities and therapeutic specialties, thus supporting Canada’s recognized clusters. In addition to formal institutes with physical infrastructure, the Canadian Institutes of Health Research fund thirteen virtual institutes that promote and build upon Canada's firm foundation of research excellence. These institutes engage the research community and encourage interdisciplinary, integrative health research.


• Respected regulatory system




• Excellent quality of life

Highly skilled worker Biotechnolgoy Human Resource Council Canadian Institution of Health Research Natural Sciences and Engineering Research Council Queen's University Life Science Program University of Saskatchewan College of Medicine University of Ottawa Department of Biology University of Toronto Life Science Program Top Lowest business cost in the G7 Canada's competitiveness in overall cost KPMG Business Study 2004: Cost advantage in Biomedical R&D; KPMG Business Study 2004: Cost advantage in Cinical Trials KPMG Business Study 2004: Cost advantage in Pharmaceuticals KPMG Business Study 2004: Cost advantage in Medical Devices KPMG Biotechnology CFO Roundtable Summary Report Top Vibrant R&D; community Public sector National research institutes Networks of Centres of Excellence CIHR Chairs Program Private Sector Manitoba's Life Science Leading Private Sector Companies Apotex Sanofi Pasteur Bayer Eli Lily Canada Genpharm Hermosol Janssen-Ortho Pfizer Canada Top Leading research infrastructure National Research Council Canada Life Science Parks & Incubators Top Respected regulatory system Patent Protection Sientific Research & Experimental Development Tax Credit Top Excellent quality of life Statistics on quality of life Top If you require assistance or have questions, please contact: Audrey Turner Manager, Industry Development turner.audrey@ic.gc.ca (613)-957-4413 Tanya (Butt) Gadzos Trade and Investment Officer, US butt.tanya@ic.gc.ca (613)-948-1547 Krista Collins Industry Development Officer, Europe collins.krista@ic.gc.ca (613)-941-6479 Vicki Schouten Senior Industry Development Officer, Asia schouten.vicki@ic.gc.ca (613)-954-3068 Mary Boreskie Industry Development Officer, Medical Devices boreskie.mary@ic.gc.ca (613)-952-2022 John Jaworski Senior Industry Development Officer, BioIndustrial Products jaworski.john@ic.gc.ca (613)-954-1035 Saeed Khan Industry Development Officer, Bio-Products khan.saeed@ic.gc.ca (613)-941-9218 Created: 2005-06-01 Updated: 2006-02-08 Top of Page Important Notices